Article
Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis.
Antimicrobial agents and chemotherapy - 1 Mar 2018
Dompreh Albert, Tang Xiaoli, Zhou Jianlin, Yang Hongmei, Topletz Ariel, Adu Ahwireng Eugene, Antwi Sampson, Enimil Antony, Langaee Taimour, Peloquin Charles A, Court Michael H, Kwara Awewura
Abstract excerpt
Isoniazid and rifampin are essential components of first-line antituberculosis (anti-TB) therapy. Understanding the relationship between genetic factors and the pharmacokinetics of these drugs could be useful in optimizing treatment outcomes, but this is understudied in children. We investigated the relationship between N-acetyltransferase type 2 (NAT2) genotypes and isoniazid pharmacokinetics, as well as that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
